Allergan Announced That The US FDA Has Approved DALVANCE Supplementary New Drug Application (sNDA)

25 Jan
FDA approves Allergan's sNDA to update label for DALVANCE (dalbavancin) for injection

Allergan announced that the US FDA has approved the company’s supplemental New Drug Application (sNDA) Update injection DALVANCE Allergan announced that the US FDA has approved the supplemental new drug application DALVANCE <wbr> (sNDA) (dalbavancin) drug label. Extended label will … Read More »